• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

自噬相关标志物 p62、LC3 和 Beclin1 在卵巢癌中的预后相关性。

Prognostic relevance of autophagy-related markers p62, LC3, and Beclin1 in ovarian cancer.

机构信息

Ljubiša Jovanović, University Clinical Center of Serbia, Pasterova 2, 11000 Belgrade,

出版信息

Croat Med J. 2022 Oct 31;63(5):453-460. doi: 10.3325/cmj.2022.63.453.

DOI:10.3325/cmj.2022.63.453
PMID:36325670
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9648085/
Abstract

AIM

To analyze the expression of autophagy markers p62, LC3, and Beclin1 in ovarian cancer tissue and evaluate the prognostic potential of these markers.

METHODS

The study enrolled 328 patients: 122 with epithelial ovarian carcinoma, 42 with atypical proliferative tumor, and 164 with benign epithelial ovarian tumor. The expression of p62, LC3, and Beclin1 was analyzed in central and invasive tumor segments with immunohistochemistry combined with tissue microarray. The expression levels of the analyzed markers were correlated with relevant histopathology parameters.

RESULTS

The expression of all analyzed markers was most remarkable in epithelial ovarian carcinoma. There was a strong positive correlation between the expressions of p62 and LC3, while these two markers negatively correlated with Beclin1. High-grade serous carcinoma had higher p62 and LC3 levels, and lower Beclin1 levels than other tumor types. This expression profile was also observed in more advanced tumor stages.

CONCLUSION

Prominent p62 and LC3 expression in combination with weak Beclin1 expression in high-grade serous carcinoma indicates potential for the application of autophagy inhibitors in patients with this tumor subtype.

摘要

目的

分析自噬标志物 p62、LC3 和 Beclin1 在卵巢癌组织中的表达,并评估这些标志物的预后潜力。

方法

该研究纳入了 328 名患者:122 名上皮性卵巢癌患者、42 名非典型增生性肿瘤患者和 164 名良性上皮性卵巢肿瘤患者。采用免疫组织化学结合组织微阵列分析中央和侵袭性肿瘤段中 p62、LC3 和 Beclin1 的表达。分析标记物的表达水平与相关组织病理学参数相关。

结果

所有分析标记物的表达在上皮性卵巢癌中最为显著。p62 和 LC3 的表达之间存在强烈的正相关,而这两个标记物与 Beclin1 呈负相关。高级别浆液性癌的 p62 和 LC3 水平较高,Beclin1 水平较低,与其他肿瘤类型相比。这种表达模式也在更晚期的肿瘤阶段观察到。

结论

在高级别浆液性癌中,p62 和 LC3 的表达明显增强,Beclin1 的表达较弱,表明自噬抑制剂在该肿瘤亚型患者中的应用潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8723/9648085/e862ea68b6ee/CroatMedJ_63_0453-F1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8723/9648085/e862ea68b6ee/CroatMedJ_63_0453-F1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8723/9648085/e862ea68b6ee/CroatMedJ_63_0453-F1.jpg

相似文献

1
Prognostic relevance of autophagy-related markers p62, LC3, and Beclin1 in ovarian cancer.自噬相关标志物 p62、LC3 和 Beclin1 在卵巢癌中的预后相关性。
Croat Med J. 2022 Oct 31;63(5):453-460. doi: 10.3325/cmj.2022.63.453.
2
[Expression and clinical significance of microtubule-associated protein 1 light chain 3 (LC3) and Beclin1 in epithelial ovarian cancer].微管相关蛋白1轻链3(LC3)及Beclin1在上皮性卵巢癌中的表达及临床意义
Ai Zheng. 2008 Jun;27(6):595-9.
3
Prognostic significance of autophagy-related genes and in ovarian cancer: a meta-analysis.自噬相关基因和在卵巢癌中的预后意义:荟萃分析。
J Int Med Res. 2020 Nov;48(11):300060520968299. doi: 10.1177/0300060520968299.
4
Expression and clinical implication of Beclin1, HMGB1, p62, survivin, BRCA1 and ERCC1 in epithelial ovarian tumor tissues.Beclin1、HMGB1、p62、生存素、BRCA1和ERCC1在上皮性卵巢肿瘤组织中的表达及临床意义
Eur Rev Med Pharmacol Sci. 2016 May;20(10):1993-2003.
5
Predictive and prognostic implications of 4E-BP1, Beclin-1, and LC3 for cetuximab treatment combined with chemotherapy in advanced colorectal cancer with wild-type KRAS: Analysis from real-world data.预测和预后意义的 4E-BP1、Beclin-1 和 LC3 西妥昔单抗联合化疗治疗野生型 KRAS 晚期结直肠癌的:来自真实世界数据的分析。
World J Gastroenterol. 2019 Apr 21;25(15):1840-1853. doi: 10.3748/wjg.v25.i15.1840.
6
Prognostic relevance of autophagy-related markers LC3, p62/sequestosome 1, Beclin-1 and ULK1 in colorectal cancer patients with respect to KRAS mutational status.自噬相关标志物LC3、p62/隔离小体1、Beclin-1和ULK1在KRAS突变状态方面对结直肠癌患者的预后相关性。
World J Surg Oncol. 2016 Jul 22;14(1):189. doi: 10.1186/s12957-016-0946-x.
7
Lower mRNA and protein expression levels of LC3 and Beclin1, markers of autophagy, were correlated with progression of renal clear cell carcinoma.自噬标志物 LC3 和 Beclin1 的 mRNA 和蛋白表达水平降低与肾透明细胞癌的进展相关。
Jpn J Clin Oncol. 2013 Dec;43(12):1261-8. doi: 10.1093/jjco/hyt160. Epub 2013 Nov 1.
8
Prognostic value of the autophagy markers LC3 and p62/SQSTM1 in early-stage non-small cell lung cancer.自噬标志物LC3和p62/SQSTM1在早期非小细胞肺癌中的预后价值
Oncotarget. 2016 Jun 28;7(26):39544-39555. doi: 10.18632/oncotarget.9647.
9
[Role of high mobility group box-1 in chemo-sensitivity in cervical cancer].高迁移率族蛋白B1在宫颈癌化疗敏感性中的作用
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2018 Jan 28;43(1):14-21. doi: 10.11817/j.issn.1672-7347.2018.01.003.
10
Autophagy-related genes Raptor, Rictor, and Beclin1 expression and relationship with multidrug resistance in colorectal carcinoma.自噬相关基因Raptor、Rictor和Beclin1在结直肠癌中的表达及其与多药耐药的关系
Hum Pathol. 2015 Nov;46(11):1752-9. doi: 10.1016/j.humpath.2015.07.016. Epub 2015 Jul 30.

引用本文的文献

1
DHRS9 promotes malignant progression of ovarian cancer through SQSTM1.DHRS9通过SQSTM1促进卵巢癌的恶性进展。
J Cancer Res Clin Oncol. 2025 Aug 27;151(8):236. doi: 10.1007/s00432-025-06290-y.
2
Assessing Autophagy Activation in Advanced Ovarian Cancer Using Ascitic Fluid: A Feasibility Study.利用腹水评估晚期卵巢癌中的自噬激活:一项可行性研究。
Cureus. 2025 Feb 20;17(2):e79371. doi: 10.7759/cureus.79371. eCollection 2025 Feb.
3
Linoleic Acid Enhances Renal Tubular Epithelial Cells Autophagy Caused by Calcium Oxalate Monohydrate Crystals.

本文引用的文献

1
PD-L1 Expression in Different Segments and Histological Types of Ovarian Cancer According to Lymphocytic Infiltrate.根据淋巴细胞浸润情况分析卵巢癌不同节段和组织学类型的 PD-L1 表达
Medicina (Kaunas). 2021 Nov 29;57(12):1309. doi: 10.3390/medicina57121309.
2
Prognostic significance of autophagy-related genes and in ovarian cancer: a meta-analysis.自噬相关基因和在卵巢癌中的预后意义:荟萃分析。
J Int Med Res. 2020 Nov;48(11):300060520968299. doi: 10.1177/0300060520968299.
3
Cancer statistics, 2020.癌症统计数据,2020 年。
亚油酸增强一水合草酸钙晶体引起的肾小管上皮细胞自噬。
J Cell Mol Med. 2024 Dec;28(24):e70250. doi: 10.1111/jcmm.70250.
4
[Luteolin inhibits proliferation of lung cancer A549 cells by increasing ROS production and inhibiting the AKT/mTOR signaling pathway and HO-1 expression].木犀草素通过增加活性氧生成、抑制AKT/mTOR信号通路和血红素加氧酶-1表达来抑制肺癌A549细胞增殖
Nan Fang Yi Ke Da Xue Xue Bao. 2024 Dec 20;44(12):2367-2374. doi: 10.12122/j.issn.1673-4254.2024.12.12.
5
Immunoexpression of autophagy‑related proteins in a single‑center series of sporadic adult conventional clival chordomas.散发型成人常规斜坡脊索瘤单中心系列中自噬相关蛋白的免疫表达
Oncol Lett. 2024 Oct 25;29(1):32. doi: 10.3892/ol.2024.14778. eCollection 2025 Jan.
6
Zinc finger domain of p62/SQSTM1 is involved in the necroptosis of human cisplatin‑resistant ovarian cancer cells treated with sulfasalazine.p62/SQSTM1的锌指结构域参与柳氮磺胺吡啶处理的人顺铂耐药卵巢癌细胞的坏死性凋亡。
Oncol Lett. 2024 Sep 3;28(5):529. doi: 10.3892/ol.2024.14662. eCollection 2024 Nov.
7
Protective effect of irbesartan against hepatic ischemia-reperfusion injury in rats: role of ERK, STAT3, and PPAR-γ inflammatory pathways in rats.厄贝沙坦对大鼠肝脏缺血再灌注损伤的保护作用:ERK、STAT3和PPAR-γ炎症通路在大鼠中的作用
Naunyn Schmiedebergs Arch Pharmacol. 2025 Feb;398(2):1681-1693. doi: 10.1007/s00210-024-03301-6. Epub 2024 Aug 21.
CA Cancer J Clin. 2020 Jan;70(1):7-30. doi: 10.3322/caac.21590. Epub 2020 Jan 8.
4
The Role of Autophagy in Cancer.自噬在癌症中的作用。
Annu Rev Cancer Biol. 2017 Mar;1:19-39. doi: 10.1146/annurev-cancerbio-041816-122338.
5
Expression and role of autophagy-associated p62 (SQSTM1) in multidrug resistant ovarian cancer.自噬相关 p62(SQSTM1)在多药耐药性卵巢癌中的表达及作用。
Gynecol Oncol. 2018 Jul;150(1):143-150. doi: 10.1016/j.ygyno.2018.04.557. Epub 2018 Apr 24.
6
Autophagy Modulation in Cancer: Current Knowledge on Action and Therapy.自噬在癌症中的调控:作用与治疗的现有知识。
Oxid Med Cell Longev. 2018 Jan 31;2018:8023821. doi: 10.1155/2018/8023821. eCollection 2018.
7
Biomarkers of platinum resistance in ovarian cancer: what can we use to improve treatment.卵巢癌铂耐药的生物标志物:我们可以用什么来改善治疗。
Endocr Relat Cancer. 2018 May;25(5):R303-R318. doi: 10.1530/ERC-17-0336. Epub 2018 Feb 27.
8
Loss of beclin 1 expression in ovarian cancer: A potential biomarker for predicting unfavorable outcomes.卵巢癌中Beclin 1表达缺失:一种预测不良预后的潜在生物标志物。
Oncol Lett. 2018 Jan;15(1):1170-1176. doi: 10.3892/ol.2017.7379. Epub 2017 Nov 9.
9
Clinical Applications of Autophagy Proteins in Cancer: From Potential Targets to Biomarkers.自噬蛋白在癌症中的临床应用:从潜在靶点到生物标志物
Int J Mol Sci. 2017 Jul 11;18(7):1496. doi: 10.3390/ijms18071496.
10
Autophagic Mechanism in Anti-Cancer Immunity: Its Pros and Cons for Cancer Therapy.抗癌免疫中的自噬机制:其在癌症治疗中的利弊
Int J Mol Sci. 2017 Jun 19;18(6):1297. doi: 10.3390/ijms18061297.